These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10709145)

  • 1. [The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
    O'Hara K; Nakamura A; Sawai T; Hosino K; Iwai Y; Nakamura S; Seto I
    Jpn J Antibiot; 2000 Jan; 53(1):46-59. PubMed ID: 10709145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
    Okubo T; Iyobe S
    Jpn J Antibiot; 2002 Oct; 55(5):514-23. PubMed ID: 12532635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
    Higurashi Y; Okuzumi K; Yoneyama A; Nakahara K
    Jpn J Antibiot; 1997 Dec; 50(12):907-16. PubMed ID: 9545668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial activities of gentamicin against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K; Fukumoto T
    Jpn J Antibiot; 1990 Oct; 43(10):1674-84. PubMed ID: 2128340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
    Yamashiro Y; Ogake N; Takahata M; Minami S
    Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of nosocomial isolates against a new aminoglycoside isepamicin.
    Kapil A; Bali R; Das BK
    Indian J Med Res; 2001 Feb; 113():60-2. PubMed ID: 21910285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nationwide survey on susceptibilities of clinical isolates to antibacterial agents in 1991].
    Tabe Y; Igari J
    Jpn J Antibiot; 1995 Mar; 48(3):409-20. PubMed ID: 7752454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 2. The results against enterobacteriaceae].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1996 Mar; 49(3):279-88. PubMed ID: 8935124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity of gentamicin against clinical isolates in pediatrics].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K; Kato M
    Jpn J Antibiot; 1988 May; 41(5):530-7. PubMed ID: 3216475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activities of isepamicin against fresh clinical isolates of gram-negative bacilli].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukamoto T
    Jpn J Antibiot; 1994 Aug; 47(8):1053-64. PubMed ID: 7933534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
    Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.